EU regulator rejects Alzheimer's drug lecanemab on July 26, 2024 Get link Facebook X Pinterest Email Other Apps It said the benefits of the treatment did not outweigh the risk of serious side effects. from BBC News https://ift.tt/eCnTXFK Comments
Comments
Post a Comment